| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.51B | 58.28B | 63.60B | 60.34B | 49.69B | 39.65B |
| Gross Profit | 21.82B | 21.60B | 22.95B | 23.15B | 19.02B | 15.45B |
| EBITDA | 14.40B | 14.11B | 15.83B | 15.85B | 13.07B | 9.94B |
| Net Income | 8.47B | 8.09B | 8.73B | 9.43B | 8.40B | 7.06B |
Balance Sheet | ||||||
| Total Assets | 83.04B | 80.38B | 83.59B | 67.78B | 61.78B | 48.58B |
| Cash, Cash Equivalents and Short-Term Investments | 9.16B | 10.94B | 7.18B | 6.40B | 7.33B | 10.79B |
| Total Debt | 19.73B | 21.02B | 21.57B | 13.56B | 10.74B | 9.18B |
| Total Liabilities | 37.38B | 38.11B | 40.41B | 30.57B | 28.27B | 22.80B |
| Stockholders Equity | 45.65B | 42.26B | 42.76B | 36.82B | 33.02B | 25.73B |
Cash Flow | ||||||
| Free Cash Flow | 8.02B | 8.45B | 8.60B | 5.46B | 4.54B | 6.68B |
| Operating Cash Flow | 10.07B | 10.37B | 10.46B | 7.14B | 5.56B | 7.61B |
| Investing Cash Flow | -3.39B | -2.77B | -11.69B | -5.24B | -5.99B | -3.47B |
| Financing Cash Flow | -6.40B | -4.95B | 1.90B | -2.64B | -3.23B | -8.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $431.29B | 32.20 | 47.51% | 0.98% | 11.85% | -2.07% | |
71 Outperform | $34.37B | 32.27 | 21.07% | ― | 5.58% | 7.51% | |
66 Neutral | $9.82B | 14.86 | 14.57% | 1.56% | -3.10% | -3.16% | |
65 Neutral | $159.81B | 54.83 | 18.93% | 1.34% | -2.66% | -21.47% | |
65 Neutral | $61.32B | 25.13 | 12.81% | 3.83% | -14.13% | -28.77% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | $13.42B | 487.54 | 6.58% | 2.67% | -4.05% | -62.88% |